Evotec SE and Almirall S.A. Advance Dermatology Drug Candidate to Preclinical Stage
The Evotec–Almirall collaboration showcases the power of AI-driven drug discovery, rapidly advancing a promising dermatology candidate toward clinical development for unmet medical needs.
Evotec SE | 05/05/2026 | By News Bureau
Sandoz to Acquire Just-Evotec Biologics in USD 300 Million Deal
Sandoz has signed a non-binding term sheet with Evotec SE, paving the way for the potential acquisition of Just–Evotec Biologics EU SAS for approximately USD 300 million.
Evotec SE | 30/07/2025 | By Dineshwori | 370
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy